Daré Bioscience, Inc.
DARE
$0.72
$0.011.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.62M | 18.52M | 24.71M | 23.08M | 5.04M |
| Total Receivables | 56.40K | 287.80K | 573.10K | 369.20K | 188.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.78M | 1.77M | 3.74M | 1.51M | 1.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.24M | 1.08M | 387.10K | 53.20K | -- |
| Total Current Assets | 16.69M | 21.66M | 27.06M | 25.00M | 6.60M |
|
|
|||||
| Total Current Assets | 16.69M | 21.66M | 27.06M | 25.00M | 6.60M |
| Net Property, Plant & Equipment | 3.13M | 3.73M | 4.40M | 4.73M | 5.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.55M | 2.44M | 1.01M | 1.02M | 1.07M |
| Total Assets | 22.37M | 27.83M | 32.47M | 30.75M | 12.98M |
|
|
|||||
| Total Accounts Payable | 762.90K | 1.23M | 1.20M | 1.84M | 1.76M |
| Total Accrued Expenses | 448.90K | 529.30K | 725.20K | 2.32M | 2.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 756.00K | 1.21M | 2.11M | 2.49M | 2.42M |
| Total Finance Division Other Current Liabilities | 14.95M | 18.15M | 19.65M | 14.56M | 12.51M |
| Total Other Current Liabilities | 14.95M | 18.15M | 19.65M | 14.56M | 12.51M |
| Total Current Liabilities | 16.92M | 21.12M | 23.69M | 21.22M | 19.22M |
|
|
|||||
| Total Current Liabilities | 16.92M | 21.12M | 23.69M | 21.22M | 19.22M |
| Long-Term Debt | 5.73M | 5.56M | 5.39M | 5.22M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 273.90K | 418.30K | 559.40K | 453.80K | 612.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.00M | 5.88M |
| Total Liabilities | 22.93M | 27.09M | 29.63M | 27.89M | 25.71M |
|
|
|||||
| Common Stock & APIC | 194.49M | 192.80M | 191.95M | 190.50M | 171.35M |
| Retained Earnings | -194.67M | -191.69M | -188.69M | -187.25M | -183.68M |
| Treasury Stock & Other | -374.90K | -377.10K | -421.60K | -396.00K | -402.80K |
| Total Common Equity | -560.90K | 733.80K | 2.84M | 2.86M | -12.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 800.00 | 700.00 | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 800.00 | 700.00 | -- | -- | -- |
|
|
|||||
| Total Common Equity | -560.90K | 733.80K | 2.84M | 2.86M | -12.73M |
| Total Preferred Equity | 800.00 | 700.00 | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -560.10K | 734.50K | 2.84M | 2.86M | -12.73M |
|
|
|||||